Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Acta Pharmacologica Et Toxicologica|January 1, 1986
Calcium channel blockade and renal functionI Odar-CederlöfActa Psychiatrica Scandinavica. Supplementum|January 1, 1978
The pharmacokinetic profile of oxazepamG Alván, I Odar-CederlöfClinical Pharmacology and Therapeutics|July 1, 1976
Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acidI Odar-Cederlöf, O BorgaEuropean Journal of Clinical Pharmacology|January 1, 1977
Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentrationM Ehrnebo, I Odar-CederlöfEuropean Journal of Clinical Pharmacology|January 1, 1987
Kinetics of morphine in patients with renal failureJ Säwe, I Odar-CederlöfEuropean Journal of Clinical Pharmacology|August 14, 1975
Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patientsM Ehrnebo, I Odar-CederlöfEuropean Journal of Clinical Pharmacology|January 1, 1976
Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failureI Odar-Cederlöf, O BorgåHemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
Cardiovasoactive peptides in hemodialysis patients: diagnostic tools and predictors of outcome: a review of present knowledge and future directionsI Odar-Cederlöf, C M KjellstrandJournal of Internal Medicine|May 1, 1990
Nifedipine as an antihypertensive drug in patients with renal failure--pharmacokinetics and effectsI Odar-Cederlöf, P Anderson, U BondessonRenal Failure|March 1, 1995
Renal and hemodynamic effects of diltiazem after elective major vascular surgery--a potential renoprotective agent?A S Bergman, I Odar-Cederlöf, L WestmanPageof 4